Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “T Lymphocyte Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT04453345
What this trial is testing

TPM Regimen (Thalidomide, Prednisone and Methotrexate) in LGLL

Who this might be right for
T-LGL LeukemiaClpd-Nk
Institute of Hematology & Blood Diseases Hospital, China 42
Not applicableNot Yet RecruitingNCT07477769
What this trial is testing

Lymphocyte Phenotype of Autosomal Recessive Congenital Ichthyoses Mutated NIPAL4 (Nipal4-nEDD)

Who this might be right for
Sezary SyndromeIchthyosis, Lamellar
Assistance Publique - Hôpitaux de Paris 10
Testing effectiveness (Phase 2)Study completedNCT05538195
What this trial is testing

Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid Tumors

Who this might be right for
Gastric CancerColon CancerRectal Cancer+2 more
Chongqing Precision Biotech Co., Ltd 17
Early research (Phase 1)Looking for participantsNCT07035002
What this trial is testing

Study on the Safety and Tolerability of PD-1 Knockout Tumor-infiltrating T Cells (TILs) in the Treatment of Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer (CRC)Tumor Infiltrating LymphocytesPD-1
Ruijin Hospital 29
Not applicableLooking for participantsNCT04924712
What this trial is testing

INS, B Cells and Microbiota

Who this might be right for
MicrobiotaB-lymphocytesGlomerulosclerosis+1 more
Nantes University Hospital 30
Early research (Phase 1)Ended earlyNCT04219319
What this trial is testing

LCAR-T2C CAR-T Cells in Relapsed or Refractory CD4+ T-cell Lymphoma

Who this might be right for
CD4+ T Lymphocyte Tumor (T Cell Lymphoma and T Cell Leukemia)
The First Affiliated Hospital with Nanjing Medical University 4
Testing effectiveness (Phase 2)Study completedNCT00005802
What this trial is testing

Chemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic Leukemia

Who this might be right for
Leukemia
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01570283
What this trial is testing

ARMS - Rapidly Generated Multivirus-Specific CTLs for Prophylaxis & Treatment of EBV, CMV, Adenovirus, HHV6 & BK Virus

Who this might be right for
Viral Infection
AlloVir 21
Early research (Phase 1)Study completedNCT01460901
What this trial is testing

Study of Donor Derived, Multi-virus-specific, Cytotoxic T-Lymphocytes for Relapsed/Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
Children's Mercy Hospital Kansas City 5
Early research (Phase 1)Ended earlyNCT00469820
What this trial is testing

Vaccine Therapy With or Without Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Multiple Myeloma Undergoing Donor Stem Cell Transplant

Who this might be right for
LeukemiaMultiple Myeloma and Plasma Cell Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 1
Not applicableWithdrawnNCT03236558
What this trial is testing

The Role of the Thymus in Type I Diabetes.

Who this might be right for
Type1 Diabetes
University Hospital, Toulouse
Not applicableStudy completedNCT03464448
What this trial is testing

Mechanistic Studies of Teriflunomide in RRMS

Who this might be right for
Relapsing Remitting Multiple Sclerosis
University of Michigan 30
Testing effectiveness (Phase 2)UnknownNCT02315118
What this trial is testing

Pilot Study of Autologous T Lymphocytes With ADCC in Patients With CD20-Positive B-Cell Malignancies

Who this might be right for
B-Cell Chronic Lymphocytic LeukemiaNon-Hodgkin's Lymphoma
National University Hospital, Singapore 18
Testing effectiveness (Phase 2)Study completedNCT01081223
What this trial is testing

Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma

Who this might be right for
GliomaHigh Grade AstrocytomaGlioblastoma Multiforme
TVAX Biomedical 12
Testing effectiveness (Phase 2)Ended earlyNCT00003910
What this trial is testing

Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia

Who this might be right for
Leukemia
Eastern Cooperative Oncology Group 59
Early research (Phase 1)Ended earlyNCT00004058
What this trial is testing

12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
University of Medicine and Dentistry of New Jersey
Early research (Phase 1)Ended earlyNCT01081808
What this trial is testing

Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and Sargramostim (GM-CSF) in Treating Advanced Solid Tumors

Who this might be right for
NeoplasmsTumorsSolid Tumors+1 more
Roger Williams Medical Center 2
Early research (Phase 1)Active Not RecruitingNCT00881920
What this trial is testing

Kappa-CD28 T Lymphocytes, Chronic Lymphocytic Leukemia, B-cell Lymphoma or Multiple Myeloma, CHARKALL

Who this might be right for
LymphomaMyelomaLeukemia
Baylor College of Medicine 54
Testing effectiveness (Phase 2)Study completedNCT03093350
What this trial is testing

TACTIC - TAA Specific Cytotoxic T Lymphocytes in Patients With Breast Cancer

Who this might be right for
Breast Cancer
Baylor College of Medicine 12
Testing effectiveness (Phase 2)Looking for participantsNCT06530576
What this trial is testing

Thalidomide for the Symptomatic Large Granular Lymphocytic Leukemia

Who this might be right for
T-LGL LeukemiaNK-LGL Leukemia
Institute of Hematology & Blood Diseases Hospital, China 48
Next Page